JNJ vs VTRS
Johnson & Johnson (JNJ) and Viatris (VTRS) compared side by side. Johnson & Johnson (JNJ) is larger, with a market cap of $635.1B versus $20.7B for Viatris, about 30.7 times the size. VTRS returned +80.8% over the past year including dividends, versus +40.2% for JNJ, through October 23, 2026..
Head to head
| Metric | JNJ | VTRS |
|---|---|---|
| Market cap | $635.1B | $20.7B |
| P/E (TTM) | 40.0x | — |
| Forward P/E | 22.7x | 6.7x |
| Revenue (TTM) | $99.3B | $14.7B |
| Revenue growth | 5.9% | 4.9% |
| Gross margin | 67.8% | 40.3% |
| Operating margin | 25.7% | 12.6% |
| Free cash flow | $22.2B | $1.8B |
| Dividend yield | 2.03% | 2.67% |
| 1-year return | +40.2% | +80.8% |
| 5-year return (annual) | +13.1% | +9.8% |
| Max drawdown | -51% | -89% |
| FI Handbook grade | B- | C- |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
$5.0K
$10.0K
$15.0K
20222023202420252026
JNJ vs VTRS FAQ
Which is bigger, JNJ or VTRS?
Johnson & Johnson (JNJ) is larger, with a market cap of $635.1B versus $20.7B for Viatris, about 30.7 times the size.
Which stock performed better over the past year, JNJ or VTRS?
VTRS returned +80.8% over the past year including dividends, versus +40.2% for JNJ, through October 23, 2026.
Which pays a higher dividend, JNJ or VTRS?
VTRS yields 2.67% versus 2.03% for JNJ.
Full pages: Johnson & Johnson · Viatris